Boston Research & Management Inc / ABT
Boston Research & Management Inc’s Abbott Laboratories Position
Does Boston Research & Management Inc own Abbott Laboratories (ABT)? Yes — 59.7K shares worth $6M (+1.46% of its 13F portfolio) as of Q1 2026, up from 56.7K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
59.7K
% of Portfolio
+1.46%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 59.7K | $6M | +1.46% |
| Q4 2025 | 56.7K | $7M | +1.64% |
| Q3 2025 | 59.3K | $8M | +1.75% |
| Q2 2025 | 58.4K | $8M | +1.90% |
| Q1 2025 | 59.3K | $8M | +1.95% |
| Q4 2024 | 62.4K | $7M | +1.73% |
| Q3 2024 | 62.4K | $7M | +1.67% |
| Q2 2024 | 61.9K | $6M | +1.63% |
| Q1 2024 | 61.8K | $7M | +1.74% |
| Q4 2023 | 61.7K | $7M | +1.80% |
| Q3 2023 | 60.4K | $6M | +1.73% |
| Q2 2023 | 59.9K | $7M | +1.85% |
| Q1 2023 | 59.6K | $6M | +1.80% |
| Q4 2022 | 59.0K | $6M | +2.00% |
| Q3 2022 | 61.1K | $6M | +2.02% |
| Q2 2022 | 58.7K | $6M | +2.07% |
| Q1 2022 | 58.1K | $7M | +1.99% |
| Q4 2021 | 59.3K | $8M | +2.28% |
| Q3 2021 | 59.4K | $7M | +2.09% |
| Q2 2021 | 58.9K | $7M | +2.07% |
| Q1 2021 | 56.6K | $7M | +2.18% |
| Q4 2020 | 57.7K | $6M | +2.20% |
| Q3 2020 | 57.9K | $6M | +2.46% |
| Q2 2020 | 60.2K | $6M | +2.29% |
| Q1 2020 | 60.4K | $5M | +2.39% |
| Q4 2019 | 60.7K | $5M | +1.98% |
| Q3 2019 | 61.0K | $5M | +2.02% |
| Q2 2019 | 61.9K | $5M | +2.11% |
| Q1 2019 | 62.6K | $5M | +2.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Research & Management Inc’s full portfolio or all institutional holders of ABT.